Bone Metastases in Castration-Resistant Prostate Cancer: Associations between Morphologic CT Patterns, Glycolytic Activity, and Androgen Receptor Expression on PET and Overall Survival

CT, fluorine 18 (18F) fluorodeoxyglucose PET, and 18F 16β-fluoro-5-dihydrotestosterone PET provided clinically relevant prognostic information in patients with bone metastases from castration-resistant prostate cancer, and imaging features such as CT lesion morphologic analysis, total number of bone lesions, and degree of androgen receptor expression were significantly associated with patient survival.